Taxus Cardium Pharmaceuticals Group Inc. – ‘SC 13D’ on 4/24/03 re: Aquentium Inc

On:  Thursday, 4/24/03, at 5:10pm ET   ·   Accession #:  1113182-3-86   ·   File #:  5-46790

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership              4     23K 

Document Table of Contents

SC 13D
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, DC 20549

----------------

SCHEDULE 13D  
(Rule 13d-101)  

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT 
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 
RULE 13d-2(a) 

(Amendment No. __________ )(1)

AQUENTIUM, INC. 
--------------------------------------------------------------------------------
(Name of Issuer)

COMMON STOCK, $0.005 PAR VALUE
--------------------------------------------------------------------------------
(Title of Class of Securities)

 03840C 10 1
--------------------------------------------------------------------------------
(CUSIP Number)

ROBERT N. WEINGARTEN
ARIES VENTURES INC. 
 28720 CANWOOD STREET, SUITE 207
 AGOURA HILLS, CALIFORNA 91301
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person 
Authorized to Receive Notices and Communications) 

FEBRUARY 19, 2002 
--------------------------------------------------------------------------------
 (Date of Event which Requires Filing of This Statement)

  If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing  
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the         
following box [_].                                                              

         Note: Schedules filed in paper format shall include a signed original
     and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.                          

(Continued on following pages)
(Page 1 of 6 Pages) 

----------                                                                      

(1)  The remainder of this cover page shall be filled out for a reporting       
   person's initial filing on this form with respect to the subject class of
   securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.               

   The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange   
Act of 1934 or otherwise subject to the liabilities of that section of the Act  
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

SC 13D
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
CUSIP No.038402 10 1                     13D                   Page 1 of 3 Pages

________________________________________________________________________________
1    NAME OF REPORTING PERSONS                                                  
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)           

ARIES VENTURES INC.                                                   
84-0987840                                                            
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_]             

________________________________________________________________________________
3    SEC USE ONLY                                                               

________________________________________________________________________________
4    SOURCE OF FUNDS*                                                           

WC                                                                    
________________________________________________________________________________
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                   
PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]  

________________________________________________________________________________
6    CITIZENSHIP OR PLACE OF ORGANIZATION                                       

NEVADA                                                                
________________________________________________________________________________
7    SOLE VOTING POWER                            

NUMBER OF         1,250,000 SHARES (1)                                      

   SHARES      _________________________________________________________________
8    SHARED VOTING POWER                          
BENEFICIALLY                                                                    
NONE                                    
OWNED BY                                                                    
               _________________________________________________________________
EACH       9    SOLE DISPOSITIVE POWER                                  

REPORTING         1,250,000 SHARES (1)                                      

   PERSON      _________________________________________________________________
10   SHARED DISPOSITIVE POWER                     
WITH                                                                    
NONE                                    

________________________________________________________________________________
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON               

1,250,000 SHARES                                                      

________________________________________________________________________________
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*     

                                                               [_]

________________________________________________________________________________
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                         

17.4%(2)                                                                

________________________________________________________________________________
14   TYPE OF REPORTING PERSON*                                                  

CO                                                                    
________________________________________________________________________________

(1) The share amounts listed above include immediately exercise warrants to     
purchase 250,000 shares of the Aquentium, Inc.'s common stock beneficially held 
by Aries Ventures Inc.                                                          

(2) The percentage calculation listed above assumes the exercise of all warrants
beneficially held by Aries Ventures Inc. (but not the exercise of stock options 
or warrants held by others) pursuant to the applicable rules and regulations of 
the Securities and Exchange Commission.                                         

________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT! 

SC 13D
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
CUSIP No.038402 10 1                     13D                   Page 2 of 3 Pages

________________________________________________________________________________
Item 1.  Security and Issuer.                                                   

Common stock, $0.005 par value                                                  

Mark Taggatz, President, Chief                                                  
Executive Officer and Chief                                                 
Financial Officer                                                           
Aquentium, Inc.                                                                 
31500 Grape Street                                                              
Suite 3401                                                                      
Lake Elsinore, California  92532                                                

________________________________________________________________________________
Item 2.  Identity and Background.                                               

(a) through (f). This statement is being filed by Aries Ventures Inc., a Nevada 
corporation ("Aries"). Aries is an investment and holding company with its      
office and principal place of business at 28720 Canwood Street, Suite 207,      
Agoura Hills, California 91301.                                                 

During the past five years, neither Aries Ventures Inc., nor any of its officers
or directors, has been (1) convicted in any criminal proceedings, or (2) was or 
is subject to a judgment, decree or final order enjoining future violations of, 
or prohibiting or mandating activities subject to, federal or state securities  
laws or finding any violation with respect to such laws, as a result of a civil 
proceeding of a judicial or administrative body of competent jurisdiction.      

________________________________________________________________________________
Item 3.  Source and Amount of Funds or Other Consideration.                     

The securities were acquired pursuant to a Share Agreement dated February 19,   
2002. No part of the purchase price for the securities was or will be           
represented by funds or other consideration borrowed or otherwise obtained for  
the purpose of acquiring, holding, trading or voting the securities.            

Effective February 19, 2002, Aries agreed to settle all outstanding debts and   
claims that it had against WaterPur International, Inc., a Delaware corporation,
now known as Aquentium, Inc. ("Aquentium"), by exchanging 7,900,004 shares of   
Aquentium preferred stock for 1,000,000 shares of Aquentium common stock and    
warrants to purchase 250,000 shares of Aquentium common stock exercisable for a 
period of three years at $1.00 per share. Aries received anti-dilution          
protection with respect to the common stock, which is calculated separately on  
December 31, 2002 and 2003, as long as Aries continues to own such shares, and  
if the aggregate market value of Aquentium's common stock and the common stock  
of any Aquentium spin-offs owned by Aries is less than $12,000,000. If the      
aggregate market value of the 1,000,000 shares of Aquentium common stock        
received by Aries, combined with the aggregate market value of any common stock 
received by Aries through one or more spin-off transactions that Aquentium may  
conduct, is less than $12,000,000, then Aries will be entitled to receive       
without the payment of any additional consideration, a sufficient number of     
newly-issued common shares of Aquentium such that Aries will own 10% of the     
outstanding shares of Aquentium common stock.                                   

In conjunction with this settlement, the acquisitions previously effected by    
WaterPur International, Inc. on May 10, 1999 were rescinded, and WaterPur       
International, Inc. acquired Aquentium, Inc., an investment and holding company 
incorporated in the state of Nevada, in a reverse merger transaction and changed
its name to "Aquentium, Inc."                                                   

________________________________________________________________________________
Item 4.  Purpose of Transaction.                                                

Aries acquired its securities in Aquentium as an investment. Aries has no       
representation in the management or Board of Directors of Aquentium. Aries has  
no current plans to acquire any additional securities of Aquentium. Aries will  
periodically evaluate Aquentium's business and prospects, and based upon future 
developments (including, without limitation, the performance of Aquentium's     
common shares in the market, the working capital requirements of Aries, and the 
alternative uses of Aries' funds, as well as the performance of the securities  
markets and economic conditions in general), Aries may, from time to time,      
dispose of all or a portion of such shares held by it, or cease selling such    
shares. Any sales may be in the open market or pursuant to privately-negotiated 
transactions or otherwise.                                                      

Except as otherwise described herein, Aries has not formulated any plans or     
proposals which relate to or would result in any matter required to be disclosed
in response to parts (a) through (j) of Item 4.                                 

________________________________________________________________________________
Item 5.  Interest in Securities of the Issuer.                                  

(a) As of January 30, 2003, Aries beneficially owned 1,250,000 shares of common 
stock of Aquentium (including 250,000 shares represented by immediately         
exercisable common stock purchase warrants), which constitutes 17.4% of         
Aquentium's 6,936,763 shares of common stock outstanding on such date, as       
calculated pursuant to the rules and regulations of the Securities and Exchange 
Commission. This calculation was made pursuant to information contained on page 
24 of Aquentium's Annual Report on Form 10-KSB for the fiscal year ended        
September 30, 2002, as filed with the Securities and Exchange Commission        

(b) Aries has sole power to vote or direct the vote of, and sole power to       
dispose or to direct the disposition of, of the 1,250,000 shares of Aquentium   
owned by it.                                                                    

(c) All of the securities reported on this Schedule 13D were acquired pursuant  
to the Share Agreement dated February 19, 2002. Aries has not effect any        
transactions in the securities of Aquentium between February 19, 2002 and the   
date of filing of this Schedule 13D with the Securities and Exchange Commission.

(d) Not applicable.                                                             

(e) Not applicable.                                                             

________________________________________________________________________________
Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect  
to Securities of the Issuer.                                  

There are no contracts, arrangements, understandings or relationships (legal or 
otherwise) between Aries and any person with respect to the securities of       
Aquentium, including but not limited to transfer or voting of any of the        
securities, finder's fees, joint ventures, loan or option arrangements, puts or 
calls, guarantees of profits, division of profits or losses, or the giving or   
withholding of proxies.                                                         

Pursuant to Paragraph 4 of the Share Agreement dated February 19, 2002, the     
agreed-upon restrictions with respect to the ability of Aries to sell its shares
of common stock of Aquentium expired on December 31, 2002.                      

________________________________________________________________________________
Item 7.  Material to be Filed as Exhibits.                                      

None.                                                                           

________________________________________________________________________________

SC 13D
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
SIGNATURE 

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

                APRIL 24, 2003
                                        ----------------------------------------
                                        (Date)

                          /s/ ROBERT N. WEINGARTEN
                                        ----------------------------------------
                                         (Signature)

                      ROBERT N. WEINGARTEN
           PRESIDENT
                     ARIES VENTURES INC.
                                        ----------------------------------------
                                          (Name/Title)

Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).                                       

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SC 13D’ Filing		Date		First		Last			Other Filings
		12/31/03		3					10QSB
Filed on:		4/24/03		4
		1/30/03		3
		12/31/02		3					10QSB,  NT 10-Q
		9/30/02		3					10KSB,  10KSB/A
		2/19/02		1		3
		5/10/99		3					3,  8-K
									List all Filings